HCV monoinfecteda vs. Uninfectedc | HCV/HIV coinfectedb vs. Uninfected | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
p d | RRRe | 95 % CIf | p | RRR | 95 % CI | p | n | |||
Lower limit | Upper limit | Lower limit | Upper limit | |||||||
Male (vs. Female)g | 0.164 | 0.6 | 0.3 | 1.1 | 0.083 | 0.8 | 0.4 | 1.8 | 0.589 | 541 |
Aged ≥35 years (vs. Aged <35 years) | 0.015 | 1.4 | 0.9 | 2.2 | 0.114 | 0.7 | 0.4 | 1.3 | 0.265 | 541 |
Greek nationality (vs. Non-Greek nationality) | 0.224 | 0.4 | 0.1 | 1.6 | 0.174 | 0.3 | 0.1 | 1.5 | 0.133 | 541 |
Lived in urban area in the past 5 years (vs. Lived in semi-urban/rural area) | 0.019 | 1.1 | 0.7 | 1.9 | 0.701 | 3.0 | 1.2 | 7.4 | 0.016 | 522 |
Living alone or with spouse/partner without children (vs. With familyh) | 0.012 | 2.0 | 1.2 | 3.3 | 0.007 | 2.3 | 1.2 | 4.3 | 0.013 | 541 |
Homeless ≥1 night in the past 12 months (vs. Never in the past 12 months) | <0.001 | 1.5 | 0.9 | 2.4 | 0.119 | 3.7 | 2.0 | 6.9 | <0.001 | 533 |
Did not graduate high school (12th grade) (vs. Graduated high school) | 0.022 | 1.3 | 0.8 | 2.0 | 0.225 | 2.4 | 1.3 | 4.5 | 0.007 | 536 |
Unemployed / student / other (vs. Employed) | 0.013 | 1.2 | 0.7 | 2.0 | 0.425 | 3.0 | 1.3 | 6.8 | 0.009 | 539 |
Economically inactivei (vs. Employed) | 1.1 | 0.5 | 2.2 | 0.859 | 4.3 | 1.6 | 11.7 | 0.005 | ||
Incarcerated at least once in lifetime (vs. Never) | 0.001 | 2.2 | 1.4 | 3.4 | <0.001 | 2.5 | 1.4 | 4.7 | 0.003 | 536 |
Use of primary substance ≥ 4 days a week (vs. <4 days a week) | 0.086 | 0.7 | 0.4 | 1.2 | 0.203 | 1.4 | 0.6 | 3.2 | 0.454 | 540 |
Use of ≥3 substances of abuse (vs. Use of <3 substances of abuse)j | 0.690 | 1.1 | 0.7 | 1.8 | 0.534 | 1.3 | 0.7 | 2.3 | 0.400 | 541 |
2–4 years of injection (vs. 0–1 year) | <0.001 | 1.6 | 0.5 | 4.8 | 0.404 | 8.8 | 1.0 | 78.1 | 0.051 | 535 |
5–9 years of injection (vs. 0–1 year) | 2.8 | 1.0 | 7.7 | 0.040 | 7.8 | 0.9 | 66.6 | 0.060 | ||
≥10 years of injection (vs. 0–1 year) | 6.1 | 2.4 | 15.1 | <0.001 | 11.0 | 1.4 | 87.3 | 0.023 | ||
Injected on average 2–3 times per day in the past 30 days (vs. <2 times/day) | <0.001 | 0.7 | 0.3 | 1.7 | 0.472 | 2.2 | 0.8 | 6.1 | 0.128 | 529 |
Injected on average >3 times per day in the past 30 days (vs. <2 times/day) | 1.1 | 0.5 | 2.4 | 0.824 | 5.0 | 2.1 | 11.7 | <0.001 | ||
Non-sterile syringe in last injection (vs. Sterile syringe in last injection) | 0.149 | 1.6 | 0.6 | 4.3 | 0.342 | 2.9 | 0.9 | 8.9 | 0.062 | 519 |
Shared syringes in the past 12 months (vs. Never in the past 12 months) | <0.001 | 1.7 | 0.9 | 3.1 | 0.080 | 4.5 | 2.2 | 9.1 | <0.001 | 504 |
Shared other injection equipment in the past 12 months (vs. Never in the past 12 months) | 0.024 | 1.0 | 0.6 | 1.6 | 0.989 | 2.0 | 1.1 | 3.6 | 0.026 | 506 |
Two or more sexual partners in the past 12 months (vs. <2 sexual partners) | 0.300 | 0.8 | 0.5 | 1.3 | 0.404 | 1.2 | 0.7 | 2.1 | 0.550 | 537 |
Sex in exchange for money etc. in the past 12 months (vs. Never in the past 12 months/non-active) | 0.218 | 1.8 | 0.6 | 5.2 | 0.306 | 2.9 | 0.8 | 10.0 | 0.092 | 529 |
No condom use in last intercourse (vs. Use of condom use or non-active) | 0.005 | 0.9 | 0.6 | 1.4 | 0.654 | 0.4 | 0.2 | 0.7 | 0.004 | 529 |
Ever entered treatment for drug-related problems before (vs. Never before) | 0.275 | 1.4 | 0.9 | 2.2 | 0.157 | 1.0 | 0.6 | 1.9 | 0.874 | 536 |
Never tested for HCV before (vs. Tested for HCV before) | <0.001 | 0.4 | 0.3 | 0.7 | <0.001 | 0.1 | 0.1 | 0.3 | <0.001 | 528 |
Never tested for HIV before (vs. Tested for HIV before) | <0.001 | 0.5 | 0.3 | 0.8 | 0.001 | 0.2 | 0.1 | 0.4 | <0.001 | 533 |